MAPK8 and central nervous system cancer: In the following mechanistic analyses, we found that FK866 and CHS828 remarkably enhanced ROS production and activated JNK signaling pathway in GBM cells, because the acquisition of chemoresistance in gliomas to TMZ was shown to be associated with decreased ROS production [39].